Do Recent Epidemiologic Observations Impact Who and How We Should Screen for CRC?

被引:0
|
作者
Ethan Bortniker
Joseph C. Anderson
机构
[1] Department of Veterans Affairs Medical Center,Division of Gastroenterology and Hepatology
[2] The Geisel School of Medicine at Dartmouth,undefined
[3] University of Connecticut School of Medicine,undefined
来源
关键词
Colorectal neoplasia; Risk factors; Models; Colonoscopy;
D O I
暂无
中图分类号
学科分类号
摘要
Colorectal cancer (CRC) screening is recommended to begin at age 50 for those patients with no significant family history of CRC. However, even within this group of average-risk patients, there is data to suggest that there may be variation in CRC risk. These observations suggest that perhaps CRC screening should be tailored to target those patients at higher risk for earlier or more invasive screening as compared to those individuals at lower risk. The strategy of how to identify those higher-risk patients may not be straightforward. One method might be to use single risk factors such as smoking or elevated BMI as has been suggested in the recent American College of Gastroenterology CRC screening guidelines. Another paradigm involves the use of models which incorporate several risk factors to stratify patients by risk. This article will highlight recent large studies that examine recognized CRC risk factors as well as review recently developed CRC risk models. There will also be a discussion of the application of these factors and models in an effort to make CRC screening more efficient.
引用
收藏
页码:781 / 794
页数:13
相关论文
共 50 条
  • [1] Do Recent Epidemiologic Observations Impact Who and How We Should Screen for CRC?
    Bortniker, Ethan
    Anderson, Joseph C.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (03) : 781 - 794
  • [2] Why, Who and How We Should Screen for Melanoma
    Karlijn Clarysse
    Katie Lacy
    Current Genetic Medicine Reports, 2022, 10 : 15 - 23
  • [3] Who and How Should We Screen for Primary Aldosteronism?
    Funder, John W.
    HYPERTENSION, 2023, 80 (12) : 2495 - 2500
  • [4] Why, Who and How We Should Screen for Melanoma
    Clarysse, Karlijn
    Lacy, Katie
    CURRENT GENETIC MEDICINE REPORTS, 2022, 10 (02) : 15 - 23
  • [5] A change in focus in colorectal cancer in New Zealand: not should we screen, but who and how should we screen?
    Gandhi, J.
    Eglinton, T. W.
    Frizelle, F. A.
    NEW ZEALAND MEDICAL JOURNAL, 2016, 129 (1440) : 8 - 10
  • [6] Cost effectiveness of screen-and-treat strategies for low bone mineral density: How do we screen, who do we screen and who do we treat?
    Schousboe J.T.
    Applied Health Economics and Health Policy, 2008, 6 (1) : 1 - 18
  • [7] Barrett’s Esophagus: Who and How Do We Screen?
    Bibek Saha
    Anjul Verma
    Prasad G. Iyer
    Current Treatment Options in Gastroenterology, 2024, 22 (2) : 23 - 43
  • [8] Thyroid Function during Pregnancy: Who and How Should We Screen?
    Gronowski, Ann M.
    Haddow, James
    Kilpatrick, Sarah
    Lazarus, John H.
    Negros, Roberto
    CLINICAL CHEMISTRY, 2012, 58 (10) : 1397 - 1401
  • [9] CHRONIC ENDOMETRITIS: WHO SHOULD WE SCREEN, HOW SHOULD WE TREAT, AND WHAT ARE OUTCOMES AFTER TREATMENT?
    Hogenesch, Elena
    Hojjati, Ronus
    Bakkensen, Jennifer B.
    Komorowski, Allison S.
    Pavone, Mary Ellen
    Bernardi, Lia A.
    Maniar, Kruti P.
    FERTILITY AND STERILITY, 2022, 118 (04) : E175 - E175
  • [10] Cholangiocarcinoma in primary sclerosing cholangitis: Who is at risk and how do we screen?
    de Groen, PC
    HEPATOLOGY, 2000, 31 (01) : 247 - 248